Bovogen Biologicals Ultra Low IgG FBS

Sunday, 01 December, 2019 | Supplied by: Scientifix Pty Ltd


Bovogen Biologicals’ foetal bovine serum (NZ origin) is manufactured in a fully validated sterile filtration facility, following strict GMP process, and is fully traceable. The FBS manufacturing process follows a strict quality controlled protocol.

All batches of FBS are triple 0.1 μm sterile filtered in a validated aseptic sterile filtration suite using a fully disposable closed loop filtration train. The closed-loop filtration system is fully disposable to ensure that all product contact parts are only used once, minimising any risk of contamination or human error.

The company’s latest product release is the Bovogen Ultra Low IgG FBS. Using a proprietary chromatographic process, IgG has been removed from the FBS with the ultimate goal of retaining the serum’s cellular viability and biological growth promoting activity. The IgG level in the UL IgG FBs is <0.5 ug/mL. Specific applications include monoclonal antibody research and production or where extremely low levels of IgG are required for cell culture and protein purification applications.

The product is manufactured by Bovogen Biologicals in 100 and 500 mL bottles, and distributed exclusively in Australia by Scientifix and Scientific Partners (WA).

Phone: 03 8540 5900
Related Products

Thermo Scientific AcroMetrix Coronavirus 2019 (COVID-19) RNA Control

In an effort to combat the recent coronavirus outbreak, Thermo Fisher Scientific designed and...

BioActs Fluorescent FSD Fluor Dyes

The FSD Fluor series is a panel of fluorescent dyes with good fluorescence intensity and a high...

Ansell BioClean PPE range

BioClean products are part of Ansell Limited's Life Sciences Solutions portfolio, offering a...

  • All content Copyright © 2020 Westwick-Farrow Pty Ltd